Periscope Capital’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Periscope Capital’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-600,000	Closed	-$5.96M	–	1043
2021 Q3	$5.96M	Hold	600,000	–	–	0.18%	233
2021 Q2	$6.03M	Buy	+600,000	New	+$6.05M	0.2%	210

Other funds holding ORIAU

JNE Partners London, United Kingdom $243M AUM 2.37% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $244M AUM 110.95% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Periscope Capital's ORIAU Position: Q4 2021 in Review

Periscope Capital sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q4 2021, closing a stake of 600,000 shares — an estimated $5.96M sold.

Periscope Capital first reported a position in ORIAU in Q2 2021 and held it in 2 quarters. The position peaked at $6.03M in Q2 2021. 18 funds tracked by Wall St. Rank hold ORIAU as of Q4 2021.

Periscope Capital reported no remaining Orion Biotech Opportunities Corp. Units position as of Q4 2021 after selling out during the quarter.
Periscope Capital sold 600,000 Orion Biotech Opportunities Corp. Units shares in Q4 2021, an estimated $5.96M.
Periscope Capital first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 2 quarters.
Periscope Capital's Orion Biotech Opportunities Corp. Units position peaked at $6.03M in Q2 2021.
18 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q4 2021.

Based on Periscope Capital's 13F filing for Q4 2021, filed 14 Feb 2022.